Immutep (IMMP) Current Assets (2011 - 2025)
Immutep's (IMMP) quarterly Current Assets came in at $91.8 million in Q4 2025, down 19.23% YoY from $113.6 million in Q4 2024, and down 3.88% on a QoQ basis from $95.5 million in Q2 2025.
Immutep (IMMP) Current Assets (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Current Assets data on file, last reported at $91.8 million in Q4 2025.
- Quarterly Current Assets fell 19.23% year-over-year to $91.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.8 million (down 19.23% YoY) and the FY2025 annual result came in at $95.5 million, down 24.28% from the prior year.
- Current Assets retreated to $91.8 million in Q4 2025, from $95.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $126.1 million in Q2 2024 to a low of $49.4 million in Q4 2022.
- A 5-year average of $83.6 million and a median of $84.3 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets jumped 158.05% — and 2022, when it sank 36.98%.
- Tracing IMMP's Current Assets over 5 years: stood at $78.4 million in 2021, then slumped by 36.98% to $49.4 million in 2022, then surged by 48.9% to $73.6 million in 2023, then jumped by 54.42% to $113.6 million in 2024, then slipped by 19.23% to $91.8 million in 2025.
- The last three Current Assets figures came in at $91.8 million (Q4 2025), $95.5 million (Q2 2025), and $113.6 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 1.76 Bn |
| 10 | Immutep | 56.63 Mn | -8.45 Mn | - | 91.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.78 Mn |
| Jun 30, 2025 | 95.49 Mn |
| Dec 31, 2024 | 113.63 Mn |
| Jun 30, 2024 | 126.10 Mn |
| Dec 31, 2023 | 73.59 Mn |
| Jun 30, 2023 | 90.21 Mn |
| Dec 31, 2022 | 49.42 Mn |
| Jun 30, 2022 | 65.05 Mn |
| Dec 31, 2021 | 78.42 Mn |
| Jun 30, 2021 | 52.69 Mn |
| Dec 31, 2020 | 45.51 Mn |
| Jun 30, 2020 | 20.42 Mn |
| Dec 31, 2019 | 18.35 Mn |
| Jun 30, 2019 | 16.49 Mn |
| Dec 31, 2018 | 21.76 Mn |
| Jun 30, 2018 | 21.68 Mn |
| Jun 30, 2017 | 11.96 Mn |
| Mar 31, 2017 | 12.91 Mn |
| Jun 30, 2016 | 16.18 Mn |
| Jun 30, 2015 | 6.24 Mn |